Skip to main content

Peer Review reports

From: Therapeutic efficacy of dose-reduced adjuvant chemotherapy with S-1 in patients with pancreatic cancer: a retrospective study

Original Submission
21 Jun 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
19 Jul 2022 Reviewed Reviewer Report - Victor Hugo Fonseca De Jesus
29 Jul 2022 Reviewed Reviewer Report - Chandra kumar Elechalawar
12 Aug 2022 Author responded Author comments - Takahiro Einama
Resubmission - Version 4
12 Aug 2022 Submitted Manuscript version 4
14 Aug 2022 Author responded Author comments - Takahiro Einama
Resubmission - Version 5
14 Aug 2022 Submitted Manuscript version 5
24 Aug 2022 Reviewed Reviewer Report - Victor Hugo Fonseca De Jesus
30 Aug 2022 Author responded Author comments - Takahiro Einama
Resubmission - Version 6
30 Aug 2022 Submitted Manuscript version 6
6 Sep 2022 Author responded Author comments - Takahiro Einama
Resubmission - Version 7
6 Sep 2022 Submitted Manuscript version 7
Publishing
21 Sep 2022 Editorially accepted
30 Sep 2022 Article published 10.1186/s12885-022-10116-2

You can find further information about peer review here.

Back to article page